Search

The AFFIRM Study is looking for adults who are 18 years of age or older, with moderate to severe Crohn’s disease (CD). The study is researching a study drug to see if it can safely be given subcutaneously (an injection under the skin) with the goal of inducing “remission” in adults with CD. Remission is…